| Old Articles: <Older 27241-27250 Newer> |
 |
The Motley Fool November 13, 2007 Seth Jayson |
So Much for the Efficient Market The current market volatility has made bargains of certain solidly performing companies. Investors, here are a few to take a look at: Apple... Martin Marietta Materials... Deckers Outdoor... Terra Nitrogen... Vulcan Materials...etc.  |
The Motley Fool November 13, 2007 Brian Orelli |
Another Punch in the Nose for Pfizer The FDA clears ZYRTEC-D for over-the-counter sales; marketing of the medication will now switch hands from Pfizer to Johnson & Johnson. Investors, take note.  |
The Motley Fool November 13, 2007 Brian Lawler |
Nektar's New Old Drug Pfizer returns its non-selling inhalable insulin experiment Exubera to Nektar Therapeutics today, along with $135 million in cash.  |
The Motley Fool November 13, 2007 Rick Aristotle Munarriz |
Are Microsoft and Yahoo! That Stupid? InterActiveCorp extends and expands its advertising agreement with Google for another five years.  |
The Motley Fool November 13, 2007 Rich Smith |
Corning Glows and Crows Today's guidance lights up the stock, with expectations of better sales and increased margins.  |
The Motley Fool November 13, 2007 Alyce Lomax |
Wild About Wal-Mart ... and Everybody Else Shares surge after the world's biggest retailer reports increased sales and net income in the third quarter; the "halo effect" spreads to other retailers.  |
The Motley Fool November 13, 2007 Tom Taulli |
Big Blue Adds to Its Software Empire In its latest deal, IBM agrees to shell out $5 billion for software powerhouse Cognos.  |
The Motley Fool November 13, 2007 Seth Jayson |
Microsoft From Z to A Microsoft gives a grade-A upgrade to its much-maligned Zune music player line.  |
The Motley Fool November 13, 2007 Rich Smith |
Foolish Forecast: Kohl's No Longer Cool In advance of earnings, analysts expect the retailer to show some revenue growth, but a big drop in profits.  |
The Motley Fool November 13, 2007 Rich Smith |
Ionatron Ionized The weapons manufacturer's value plummets, after quarterly earnings leave investors wondering about the future of the company.  |
| <Older 27241-27250 Newer> Return to current articles. |